Inactive Instrument

CanaFarma Hemp Products Corp.

CNFA

CA13683D1087

Canafarma Announces Resignation of Steven Katz as Interim COO

October 08, 2021 at 06:24 pm EDT

CanaFarma Hemp Products Corp. announced the resignation of Steven Katz from the position of interim Chief Operating Officer of the Company. Vitaly Fargesen and Igor Palatnik continue to serve in their roles as Senior Vice Presidents of the Company.

Latest news about CanaFarma Hemp Products Corp.

Canafarma Announces Resignation of Steven Katz as Interim COO	21-10-08	CI
CanaFarma Hemp Products : U.S. SEC charges hemp company CanaFarma and co-founders with fraud	21-10-05	RE
CanaFarma Hemp Products Corp. Announces Fully Sold First Drop of Winners Circle Products	21-09-27	CI
CanaFarma Hemp Products Corp. signed a letter of intent to acquire Avitas Bio for CAD 2.7 million.	21-09-21	CI
CanaFarma Announces Just Live® Partnering with Vertical Wellness to Launch Athlete Founded, Nature Grounded CBD Infused Sparkling Water	21-09-10	CI
CanaFarma Hemp Products Corp. announced that it has received CAD 1.672535 million in funding	21-08-19	CI
CanaFarma Hemp to Seek Acquisitions	21-07-12	CI
CanaFarma Hemp Products Corp. announced that it expects to receive CAD 5 million in funding	21-07-11	CI
David Lonsdale to Resign as CEO of CanaFarma Hemp Products Corp., Effective August 15, 2021	21-07-02	CI
CanaFarma Brief: Details MOU to Acquire Vertical Wellness; Says Combined Company Anticipated to Have a Market Capitalization of Near $50 Million	21-06-29	MT
CanaFarma Hemp Products Corp. signed a memorandum of understanding to acquire Vertical Wellness, Inc.	21-06-28	CI
Canafarma Hemp Products Corp. Reports Earnings Results for the Third Quarter Ended March 31, 2021	21-05-26	CI
CANNABIS RELATED NEWS: Core One Labs Updates On Plans For NASDAQ Listing. Also CanaFarma Hemp Products Corp; Halo Collective	21-02-08	MT
CanaFarma Hemp Products Corp. Announces Management Updates	21-01-07	CI
Canafarma Hemp Products Corp. Partners with APeT BV to Develop Novel Hemp-Based Cannabinoid, Drug and Nutritional Supplement Delivery Methods Via Its Flotexc Patented Technology	20-09-16	CI
CanaFarma Hemp Products Corp Appoints Djibril Gibson Kagni as Head of Media Management	20-08-27	CI
CanaFarma Hemp Products Corp. Announces the Launch of Its Comprehensive and Innovative Hemp Oil-Infused Anti-Aging Skin Care Line to Market	20-08-18	CI
CanaFarma Hemp Products Corp. Enters into Memorandum of Agreement with FeelGoodCBD, LLC	20-07-27	CI
CanaFarma Hemp Products Sign Exclusive Fulfillment and Production Agreement with Nutracosmetic GmbH	20-07-16	CI
CanaFarma Hemp Products Corp. Introduces Three More New Hemp Oil-Infused Chewing Gum Products	20-06-29	CI
CanaFarma Hemp Products Corp. announced that it has received CAD 5.223095 million in funding	20-06-23	CI
CanaFarma Hemp Products Corp. Announces the Launch of Two New Hemp Oil-Infused Chewing Gum Products	20-06-22	CI
Canafarma Hemp Products Corp. Announces Manufacturing Plans for Hemp Oil Infused, Center-Filled Chewing Gum	20-06-12	CI
CanaFarma Hemp Products Corp. signed a letter of intent to acquire Pharm Ops, Inc.	20-06-08	CI
CanaFarma Hemp Products Corp. Announces the Development of its Acne Cream	20-05-12	CI

Chart CanaFarma Hemp Products Corp.

Duration

Period

More charts

Company Profile

CanaFarma Hemp Products Corp. is a Canada-based fully integrated hemp products brand company. The Company is engaged in the business of growing, manufacturing, processing and selling hemp oil via an online distribution platform. The Company has three hemp-based products, such as chewing gum, tincture and creams, all of which are distributed and sold under its YOOFORIC brand. Its YOOFORIC tincture is a concentrated liquid herbal extract that is made by soaking herbs and other plant parts in alcohol for weeks to extract the active constituents. It has a YOOFORIC hemp oil-infused cream for joint and muscle support, and hemp oil-infused acne cream to combat skin conditions related specifically to acne. The Company's YOOFORIC chewing gum is produced in Europe and imported into the United States.

Sector

Pharmaceuticals

More about the company

Sector Alternative Medicine

	1st Jan change	Capi.
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-15.13%	4.51B
TASLY PHARMACEUTICAL GROUP CO., LTD	-9.75%	3.15B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+2.14%	3.1B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-6.82%	2.42B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+47.87%	1.97B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+0.09%	1.65B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-7.89%	1.68B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-12.97%	1.53B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+33.40%	1.38B

Alternative Medicine